C. Michaloglou, BRAFE600-associated senescence-like cell cycle arrest of human naevi, Nature, vol.436, issue.7051, pp.720-724, 2005.
DOI : 10.1038/nature03890

N. E. Sharpless and C. J. Sherr, Forging a signature of in vivo senescence, Nature Reviews Cancer, vol.443, issue.7, pp.397-408, 2015.
DOI : 10.1038/cddis.2014.489

C. M. Beausejour, Reversal of human cellular senescence: roles of the p53 and p16 pathways, The EMBO Journal, vol.22, issue.16, pp.4212-4222, 2003.
DOI : 10.1093/emboj/cdg417

L. C. Vredeveld, Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis, Genes & Development, vol.26, issue.10, pp.1055-1069, 2012.
DOI : 10.1101/gad.187252.112

S. De-carne-trecesson, Escape from p21-mediated Oncogene-induced Senescence Leads to Cell Dedifferentiation and Dependence on Anti-apoptotic Bcl-xL and MCL1 Proteins, Journal of Biological Chemistry, vol.25, issue.15, pp.12825-12838, 2011.
DOI : 10.1016/j.cell.2009.06.034

A. Vigneron, I. B. Roninson, E. Gamelin, and O. Coqueret, Checkpoint Arrest by Blocking the Induction of p21waf1, Cancer Research, vol.65, issue.19, pp.8927-8935, 2005.
DOI : 10.1158/0008-5472.CAN-05-0461

A. Vetillard, Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis, Oncotarget, vol.6, issue.41, pp.43342-43362, 2015.
DOI : 10.18632/oncotarget.6126

B. Jonchere, Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on antiapoptotic Mcl-1, Oncotarget, vol.6, pp.409-426, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01396743

O. Coqueret, Linking cyclins to transcriptional control, Gene, vol.299, issue.1-2, pp.35-55, 2002.
DOI : 10.1016/S0378-1119(02)01055-7

H. T. Mcmahon and E. Boucrot, Molecular mechanism and physiological functions of clathrin-mediated endocytosis, Nature Reviews Molecular Cell Biology, vol.84, issue.8, pp.517-533, 2011.
DOI : 10.1016/S0092-8674(00)81070-3

S. Ansieau and G. Collin, Senescence versus apoptosis in chemotherapy, Oncotarget, vol.6, issue.7, pp.4551-4552, 2005.
DOI : 10.18632/oncotarget.3114

A. Vigneron, E. Gamelin, and O. Coqueret, The EGFR-STAT3 Oncogenic Pathway Up-regulates the Eme1 Endonuclease to Reduce DNA Damage after Topoisomerase I Inhibition, Cancer Research, vol.68, issue.3, pp.815-825, 2008.
DOI : 10.1158/0008-5472.CAN-07-5115

P. L. Toogood, Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6, Journal of Medicinal Chemistry, vol.48, issue.7, pp.2388-2406, 2005.
DOI : 10.1021/jm049354h

A. P. Bracken, EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer, The EMBO Journal, vol.22, issue.20, pp.5323-5335, 2003.
DOI : 10.1093/emboj/cdg542

A. P. Bracken, The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells, Genes & Development, vol.21, issue.5, pp.525-530, 2007.
DOI : 10.1101/gad.415507

A. Iannetti, Regulation of p53 and Rb Links the Alternative NF-??B Pathway to EZH2 Expression and Cell Senescence, PLoS Genetics, vol.322, issue.9, p.1004642, 2014.
DOI : 10.1371/journal.pgen.1004642.s016

M. Campone, Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples, Molecular & Cellular Proteomics, vol.240, issue.4, pp.2936-2946, 2015.
DOI : 10.1158/1055-9965.EPI-09-0456

D. Besson, A Quantitative Proteomic Approach of the Different Stages of Colorectal Cancer Establishes OLFM4 as a New Nonmetastatic Tumor Marker, Molecular & Cellular Proteomics, vol.63, issue.12
DOI : 10.1158/1078-0432.CCR-07-4125

F. Rodier, Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion, Nature Cell Biology, vol.11, issue.8, pp.973-979, 2009.
DOI : 10.1074/jbc.M408650200

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743561/pdf

J. P. Coppe, Senescence-associated secretory phenotypes reveal cellnonautonomous functions of oncogenic RAS and the p53 tumor suppressor, PLoS Biol, vol.6, pp.2853-2868, 2008.

T. Kuilman, Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network, Cell, vol.133, issue.6, pp.1019-1031, 2008.
DOI : 10.1016/j.cell.2008.03.039

URL : https://doi.org/10.1016/j.cell.2008.03.039

F. Rodier and J. Campisi, Four faces of cellular senescence, The Journal of Cell Biology, vol.62, issue.4, pp.547-556, 2011.
DOI : 10.1038/sj.onc.1201178

J. P. Coppe, K. Kauser, J. Campisi, and C. M. Beausejour, Secretion of Vascular Endothelial Growth Factor by Primary Human Fibroblasts at Senescence, Journal of Biological Chemistry, vol.13, issue.40, pp.29568-29574, 2006.
DOI : 10.1101/gad.1243304

S. Parrinello, J. P. Coppe, A. Krtolica, and J. Campisi, Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation, Journal of Cell Science, vol.118, issue.3, pp.485-496, 2005.
DOI : 10.1242/jcs.01635

E. Kim, Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells, Cancer Cell, vol.23, issue.6, pp.839-852, 2013.
DOI : 10.1016/j.ccr.2013.04.008

E. Deruy, Level of macroautophagy drives senescent keratinocytes into cell death or neoplastic evasion, Cell Death & Disease, vol.19, issue.12, p.1577, 2014.
DOI : 10.1073/pnas.92.20.9363

K. Gosselin, Senescence-Associated Oxidative DNA Damage Promotes the Generation of Neoplastic Cells, Cancer Research, vol.69, issue.20, pp.7917-7925, 2009.
DOI : 10.1158/0008-5472.CAN-08-2510

C. I. Kint, N. Verstraeten, M. Fauvart, and J. Michiels, New-found fundamentals of bacterial persistence, Trends in Microbiology, vol.20, issue.12, pp.577-585, 2012.
DOI : 10.1016/j.tim.2012.08.009

O. V. Leontieva, Z. N. Demidenko, and M. V. Blagosklonny, MEK drives cyclin D1 hyperelevation during geroconversion, Cell Death & Differentiation, vol.4, issue.9, pp.1241-1249, 2013.
DOI : 10.4161/cc.21908

URL : http://www.nature.com/cdd/journal/v20/n9/pdf/cdd201386a.pdf

S. Brookes, Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence, Cell Cycle, vol.9, issue.8, pp.1164-1173, 2015.
DOI : 10.1126/science.1068999

M. T. Mccabe, EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations, Nature, vol.22, issue.7427, pp.108-112, 2012.
DOI : 10.1016/0006-2952(73)90196-2

K. Agger, The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence, Genes & Development, vol.23, issue.10, pp.1171-1176, 2009.
DOI : 10.1101/gad.510809

M. Barradas, Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS, Genes & Development, vol.23, issue.10, pp.1177-1182, 2009.
DOI : 10.1101/gad.511109